Publications by authors named "Vishak Subramoney"

Claim this Profile
E
Effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on maternal gestational weight gain in low-income and middle-income countries: a systematic review and individual participant data meta-analysis of randomised clinical trials.
Enju Liu, Uttara Partap, Sachin Shinde, Dongqing Wang, Janaína Calu Costa, Vishak Subramoney

EClinicalMedicine· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol: the International Milk Composition (IMiC) Consortium - a harmonized secondary analysis of human milk from four studies.
Kelsey Fehr, Andrew Mertens, Chi-Hung Shu, Trenton Dailey-Chwalibóg, Liat Shenhav, Vishak Subramoney

Front Nutr· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of prenatal balanced energy and protein supplementation on gestational weight gain: An individual participant data meta-analysis in low- and middle-income countries.
Dongqing Wang, Uttara Partap, Enju Liu, Janaína Calu Costa, Ilana R Cliffer, Vishak Subramoney

PLoS Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Early-childhood linear growth faltering in low- and middle-income countries.
Jade Benjamin-Chung, Andrew Mertens, John M Colford, Alan E Hubbard, Mark J van der Laan, Vishak Subramoney

Nature· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Child wasting and concurrent stunting in low- and middle-income countries.
Andrew Mertens, Jade Benjamin-Chung, John M Colford, Alan E Hubbard, Mark J van der Laan, Vishak Subramoney

Nature· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Early-childhood linear growth faltering in low- and middle-income countries.
Jade Benjamin-Chung, Andrew Mertens, John M Colford, Alan E Hubbard, Mark J van der Laan, Vishak Subramoney

Nature· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early-childhood linear growth faltering in low- and middle-income countries.
Jade Benjamin-Chung, Andrew Mertens, John M Colford, Alan E Hubbard, Mark J van der Laan, Vishak Subramoney

Nature· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Child wasting and concurrent stunting in low- and middle-income countries.
Andrew Mertens, Jade Benjamin-Chung, John M Colford, Alan E Hubbard, Mark J van der Laan, Vishak Subramoney

Nature· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causes and consequences of child growth faltering in low-resource settings.
Andrew Mertens, Jade Benjamin-Chung, John M Colford, Jeremy Coyle, Mark J van der Laan, Vishak Subramoney

Nature· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suboptimal gestational weight gain and neonatal outcomes in low and middle income countries: individual participant data meta-analysis.
Nandita Perumal, Dongqing Wang, Anne Marie Darling, Enju Liu, Molin Wang, Vishak Subramoney

BMJ· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for inadequate and excessive gestational weight gain in 25 low- and middle-income countries: An individual-level participant meta-analysis.
Anne Marie Darling, Dongqing Wang, Nandita Perumal, Enju Liu, Molin Wang, Vishak Subramoney

PLoS Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of prenatal nutritional supplements on gestational weight gain in low- and middle-income countries: a meta-analysis of individual participant data.
Enju Liu, Dongqing Wang, Anne M Darling, Nandita Perumal, Molin Wang, Vishak Subramoney

Am J Clin Nutr· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Exposure-Response Perspective on the Clinical Dose of Pretomanid.
Jerry R Nedelman, David H Salinger, Vishak Subramoney, Rob Woolson, Karen Wade

Antimicrob Agents Chemother· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of the Antituberculosis Agent Pretomanid.
David H Salinger, Vishak Subramoney, Daniel Everitt, Jerry R Nedelman

Antimicrob Agents Chemother· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of Valganciclovir in Pediatric Heart Transplant Recipients 4 Months of Age and Younger.
Denise Bradley, Sebastian Moreira, Vishak Subramoney, Clifford Chin, Jane Ives

Pediatr Infect Dis J· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating clinically adequate concentrations of oseltamivir carboxylate in end-stage renal disease patients undergoing hemodialysis using a population pharmacokinetic approach.
Mohamed A Kamal, Kayla Yi Ting Lien, Richard Robson, Vishak Subramoney, Barry Clinch

Antimicrob Agents Chemother· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of new oral dosing regimens for the neuraminidase inhibitor oseltamivir in patients with moderate and severe renal impairment.
Mohamed A Kamal, Barbara J Brennan, Vishak Subramoney, Yi Ting Kayla Lien, Peter N Morcos

Clin Pharmacol Drug Dev· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic analysis of oseltamivir and oseltamivir carboxylate following intravenous and oral administration to patients with and without renal impairment.
Leonid Gibiansky, Mylène Giraudon, Craig R Rayner, Barbara J Brennan, Vishak Subramoney

J Pharmacokinet Pharmacodyn· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of oseltamivir: pediatrics through geriatrics.
Mohamed A Kamal, Scott A Van Wart, Craig R Rayner, Vishak Subramoney, Daniel K Reynolds

Antimicrob Agents Chemother· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis